Hepatitis C in human immunodeficiency virus-coinfected patients: Increased variability in the hypervariable envelope coding domain

Hepatology

Volumn 23, Issue 4, 1996, Pages 688-694

  Sherman, Kenneth E ^a,c   Andreatta, Cindy ^b   O'Brien, Judy ^b   Gutierrez, Anthony ^b   Harris, Richard ^b  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b FITZSIMONS ARMY MEDICAL CENTER   (United States)

^c UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON; VIRUS RNA;

ADULT; AMINO ACID SEQUENCE; ANTIGENICITY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOGLOBULIN VARIABLE REGION; MALE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; VIRUS ENVELOPE; VIRUS GENOME; VIRUS HEPATITIS;

EID: 0029881316     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.1996.v23.pm0008666318     Document Type: Article

References (18)

1. Sherman KE, Freeman S, Harrison S, Andron L. Prevalence of antibody to hepatitis C virus in patients infected with the human immunodeficiency virus. J Infect Dis 1991;163:414-415.
2. Wright TL, Hollander H, Pu X, Held JM, Lipson P, Quan S, Polito A, et al. Hepatitis C in HIV-infected patients with and without AIDS: prevalence and relationship to survival. HEPATOLOGY 1994;20:1152-1155.
3. Dalton BH, Acosta A, Jacobson IM. Interferon therapy in HIV-positive patients with chronic hepatitis C. HEPATOLOGY 1992;16:199A. Abstract.
4. Sherman KE, O'Brien J, Gutierrez AG, Harrison S, Urdea M, Neuwald P, Wilber J. Quantitative evaluation of hepatitis C virus RNA in patients with concurrent human immunodeficiency virus infections. J Clin Microbiol 1993;31:2679-2682.
5. Weiner AJ, Brauer MJ, Rosenblatt J, Richman KH, Tung J, Crawford K, Bonino F, et al. Variable and hypervariable domains are found in the regions of HCV corresponding to the flavivirus envelope and NS1 proteins and the Pestivirus envelope glycoprotein. Virology 1991;189:842-848.
6. Kurosaki M, Enomoto N, Marumo F, Sato C. Rapid sequence variation of the hypervariable region of hepatitis C virus during the course of chronic infection. HEPATOLOGY 1993;18:1293-1299.
7. Weiner AJ, Geysen HM, Christopherson C, Hall JE, Mason TJ, Saracco G, Bonino F, et al. Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infections. Proc Natl Acad Sci USA 1992;89:3468-3472.
8. Okada S-I, Akahane Y, Suzuki H, Okamoto H, Mishiro S. The degree of variability in the amino terminal region of the E2/NS1 protein of hepatitis C virus correlates with responsiveness to interferon therapy in viremic patients. HEPATOLOGY 1992;16: 619-624.
9. Choo Q-L, Richman KH, Han JH, Berger K, Lee C, Dong C, et al. Genetic organization and diversity of the hepatitis C virus. Proc Natl Acad Sci U S A 1991;88:2451-2455.
10. Jameson BA, Wolf H. The antigenic index: a novel algorithm for predicting antigenic determinants. Comput Appl Biosci 1988;4: 181-186.
11. Dusheiko G, Schmilovitz-Weiss D, McOmish F, Yap P-L, Sherlock S, McIntyre N, Simmonds P. Hepatitis C virus genotypes: an investigation of type-specific differences in geographic origin and disease. HEPATOLOGY 1994;19:13-18.
12. McOmish F, Yap PL, Dow BC, Follett EAC, Seed C, Keller AJ, Cobain TJ, et al. Geographical distribution of hepatitis C virus genotypes in blood donors: an international collaborative survey. J Clin Microbiol 1994;32:884-892.
13. Fenner F, MuAuslan BR, Mims CA, Sambrook J, White DO. Evolutionary aspects of viral disease. In: The Biology of Animal Viruses. New York: Academic; 1974:618-641.
14. Okamoto H, Kojima M, Okada S-I, Yoshizawa H, Ilzuka H, Tanaka T, Muchmore EE, et al. Genetic drift of hepatitis C virus during an 8.2 year infection in a chimpanzee: variability and stability. Virology 1992;190:894-899.
15. Kumar U, Monjardino J, Thomas HC. Hypervariable region of hepatitis C virus envelope glycoprotein (E2/NS1) in an aggamglobulinemic patient. Gastroenterology 1994;106:1072-1075.
16. Eyster MS, Diamonstone LS, Lien J-M, Ehmann WC, Quan S, Goedert JJ. Natural history of hepatitis C virus infection in multitransfused hemophiliacs: effects of coinfection with human immunodeficiency virus. J Acquir Immune Defic Syndr 1993; 6:602-610.
17. Martin P, DiBisceglie AM, Kassianides C, Lisker-Melman M, Hoofnagle. Rapidly progressive non-A, non-B hepatitis in patients with human immunodeficiency virus infection. Gastroenterology 1989;97:1559-1561.
18. Moribe T, Hayashi N, Kanazawa Y, Mita E, Fusamoto H, Negi M, Kaneshige T, et al. Hepatitis C viral complexity detected by single-strand conformation polymorphism and response to interferon therapy. Gastroenterology 1995;108:789-795.